Treatment with Octreotide in Patients with Well-Differentiated Neuroendocrine Tumors of the Ileum: Prognostic Stratification with Ga-68-DOTA-TATE Positron Emission Tomography
We investigated the use of Ga-68-DOTA-Tyr 3 -octreotate (Ga-68-DOTA-TATE) positron emission tomography (PET) and standardized uptake values (SUVs) to predict the effectiveness of treatment with the somatostatin analogue octreotide acetate (Sandostatin LAR) in patients with neuroendocrine tumors (NET...
Saved in:
Main Authors: | Walter Koch, Christoph J. Auernhammer, Julia Geisler, Christine Spitzweg, Clemens C. Cyran, Harun Ilhan, Peter Bartenstein, Alexander R. Haug |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2014-06-01
|
Series: | Molecular Imaging |
Online Access: | https://doi.org/10.2310/7290.2014.00009 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Octreotide in the treatment of neuroendocrine carcinomas: Is the success achieved?
by: L. Yu. Morgunov
Published: (2015-06-01) -
Structured reporting of neuroendocrine tumors in PET/CT using [18F]SiTATE - impact on interdisciplinary communication
by: Anna Hinterberger, et al.
Published: (2025-02-01) -
Case report: Detecting giant cell arteritis in [68Ga]Ga-DOTA-Siglec-9-PET/CT
by: Simon M. Petzinna, et al.
Published: (2024-12-01) -
Refractory Thrombocytopenia Responds to Octreotide Treatment in a Case of Evans Syndrome with Gastric Neuroendocrine Tumor
by: Kocfa Chung-Delgado, et al.
Published: (2013-01-01) -
Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/MRI in the Preoperative Diagnosis of Gastric Cancer
by: Tao Du, et al.
Published: (2023-01-01)